Parcae Capital | North Andover
Combating Antibiotic Resistant Bacteria:
How the Fight is Progressing in 2016 Frank Magliochetti Report Bacteria that are resistant to common antibiotics have been around for some time. Unfortunately, they have become more widespread and more deadly than they were in times past. Following are some new major developments that may result in mankind either succumbing to antibiotic resistant […]
Nobel Peace Prize Winner for Medicine – Yoshinori Ohsumi
Dr. Yochinori Ohsumi Wins Nobel Peace Prize for Medicine Frank Magliochetti Report Yoshinori Ohsumi is the sole winner of the 2016 Nobel Prize in Physiology or Medicine. Dr. Ohsumi is a cell biologist who specializes in autophagy, which is the process cells use to destroy and recycle cellular components the cells no longer use. Ohsumi […]
ClickStream CEO Frank Magliochetti Talks about Disrupting Conventional Industries Through Apps
ClickStream CEO Talks Disruption Through Apps CLICKSTREAM CEO FRANK MAGLIOCHETTI TALKS DISRUPTING CONVENTIONAL INDUSTRIES THROUGH APPS, EXPLODING NFT TECH, AND WHY CLIS IS A SMART INVESTMENT TODAY In an incredibly thorough and and candid interview Hazel Saunders of the Ritz Herald talks with Frank M<agliochetti about all things ClickStream! Here is the Interview: for the […]
Top 3 Challenges in Healthcare in 2020
1. Cybersecurity The medical and healthcare sector collects highly sensitive patient information, which puts the industry in the crosshairs of cybersecurity attacks. There were 2,546 healthcare data breaches involving more than 500 records in the United States between 2009 and 2018, resulting in the in the exposure and theft of 189,945,874 healthcare records – this […]
OPKO
Absolute Day Trader Picks Here is a snapshot of their company. A lot is coming from this multi-national powerhouse. Company Overview OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development, and commercialization expertise and our novel […]